Data for (Study ST000075)

(Analysis AN000119)

Values for each metabolite have been scaled by dividing by the mean across all factors

Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

MetaboliteF1F2F3
1-Hexadecanoyl-sn-glycero-3-phosphocholine 0.4799 1.3581 1.3077
Acylcarnitine C16:0 0.7943 1.2065 0.2351
Acylcarnitine C18:0 1.2698 0.8571 0.2553
Acylcarnitine C18:1 0.8412 1.1768 0.1722
Acylcarnitine C18:2 1.1077 0.9804 0.1907
CE (18:1) 0.7461 1.1331 1.7197
CE (18:2) 0.9604 1.0012 1.3801
CE (20:4) 0.7227 1.2390 0.5064
CE (22:6) 0.7860 1.2198 0.1358
Cholesterol 0.9669 1.0353 0.8490
DG (36:3) 1.0157 0.8871 2.3856
LPC (15:0) 0.8103 1.1361 1.0372
LPC (16:0) 0.5816 1.2921 1.1914
LPC (16:1) 0.3788 1.4611 0.9094
LPC (18:0) 0.7027 1.2381 0.7189
LPC (18:1) 0.5640 1.3114 1.1038
LPC (18:2) 0.7522 1.2166 0.5173
LPC (20:1) 0.3259 1.5397 0.3657
LPC (20:2) 0.6024 1.3159 0.6583
LPC (20:3) 0.5188 1.3429 1.1252
LPC (20:4) 0.6193 1.3251 0.3645
LPC (20:5) 0.6157 1.3308 0.3230
LPC (22:6) 0.6128 1.3428 0.1875
N-Stearoyl-4-sphingenyl-1-O-phosphorylcholine 0.8364 0.8273 4.9970
N-Tetracosenoyl-4-sphingenyl-1-O-phosphorylcholine 0.4127 1.3954 1.4686
Oleoyl ethylamide 0.7781 1.1493 1.1777
PC (16:0/16:0) 0.7671 1.1637 1.0909
PC (18:1/16:0) 0.5531 1.2944 1.4454
PC 32:0 0.7074 1.2102 1.0530
PC (32:1) 0.3832 1.3142 2.8742
PC 32:1 0.4009 1.3240 2.5632
PC (32:2) 0.5549 1.2245 2.3825
PC (33:1) 0.5556 1.2954 1.4073
PC (33:2) 1.0132 1.0107 0.7215
PC 33:2 0.9777 1.0265 0.8602
PC (34:0) 0.6667 1.2571 0.8187
PC (34:2) 0.9554 1.0427 0.8625
PC (34:3) 0.4351 1.4483 0.5227
PC (34:4) 0.6487 1.1349 2.6688
PC (35:1) 0.8480 1.1043 1.0946
PC (35:2) 1.2305 0.8737 0.4200
PC (35:3) 0.7321 1.2379 0.4268
PC (35:4) 0.9558 1.0469 0.8009
PC (36:2) 1.0657 0.9717 0.7298
PC 36:2 1.0314 0.9809 0.9465
PC (36:3) A 1.0499 0.9783 0.7981
PC (36:4) 0.7782 1.1766 0.8038
PC 36:4 0.9477 1.0346 1.0500
PC (36:5) C 1.0363 0.9693 1.0571
PC (36:6) 0.6539 1.2497 1.0479
PC (37:2) 0.7356 1.2586 0.1096
PC (37:4) 0.9721 1.0648 0.3944
PC (37:6) 0.8812 1.1331 0.3685
PC (38:2) 0.5248 1.3771 0.5986
PC (38:4) A 0.8918 1.1081 0.6044
PC (38:5) A 0.6821 1.2627 0.5893
PC 38:6 0.8217 1.1655 0.5206
PC (38:6) A 0.7552 1.2231 0.3989
PC (39:6) 1.1626 0.9310 0.3169
PC (40:4) 0.6148 1.2691 1.1741
PC 40:6 0.9273 1.1059 0.2801
PC (40:6) A 0.9590 1.0831 0.2734
PC (40:7) 0.6295 1.3342 0.1373
PC (40:8) 0.9116 1.1290 0.1211
PC 42:10 0.7819 1.2212 0.1583
PC-O (32:0) (plasmanyl/plasmenyl) 0.6619 1.1233 2.6954
PC-O (34:1) (plasmanyl/plasmenyl) 0.8938 1.0349 1.5857
PC-O (34:2) (plasmanyl/plasmenyl) 0.8229 0.9623 3.2856
PC-O (36:2) (plasmanyl/plasmenyl) 0.9508 0.9400 2.3122
PC-O (36:3) (plasmanyl/plasmenyl) 0.9963 0.7983 3.7928
PC-O (36:4) (plasmanyl/plasmenyl) 0.8498 0.9255 3.5206
PC-O (36:5) (plasmanyl/plasmenyl) 0.9229 0.8355 4.0188
PC-O (38:4) (plasmanyl/plasmenyl) 0.8532 0.8354 4.7177
PC-O (38:6) (plasmanyl/plasmenyl) 1.1076 0.8880 1.4544
PC-O (40:4) (plasmanyl/plasmenyl) 1.0264 0.9086 1.9848
PC-O (40:7) (plasmanyl/plasmenyl) 1.0297 0.9765 1.0236
PC-O (40:8) (plasmanyl/plasmenyl) 0.9108 0.9321 2.8208
PE (38:6) 0.7584 1.2300 0.2730
PE-O (36:5) (plasmanyl/plasmenyl) 0.7566 1.0653 2.5409
PE-O (38:5) (plasmanyl/plasmenyl) 0.9333 0.8285 4.0105
plasmenyl-PE 40:6 0.9211 1.0647 0.9046
SM (33:1) 0.7575 1.1502 1.3731
SM (34:0) 0.9459 0.8405 3.7203
SM 34:1 0.8561 0.9301 3.3947
SM (d16:1/20:0) 0.8605 0.8148 4.9256
SM (d16:1/20:1) 0.7980 0.6915 7.2371
SM (d18:1/14:0) 0.5191 0.7892 8.6900
SM (d18:1/16:0) 0.9031 0.9368 2.8338
SM (d18:1/16:1) 0.7989 1.0023 2.9799
SM (d18:2/23:0) 0.4253 1.3649 1.7597
SM (d18:2/24:1) 0.6397 1.1554 2.4793
SM (d38:1) 0.5366 0.9393 6.4643
SM (d40:1) 0.5446 1.2402 2.2716
SM (d40:2) A 0.4620 1.1257 4.6629
SM (d41:1) 0.8427 1.0211 2.2850
SM (d42:1) 0.7507 1.0776 2.4323
TG (46:0) 0.9793 0.6738 5.6659
TG (48:0) 1.5595 0.4918 2.3503
TG (48:1) 0.6347 0.7005 8.7461
TG (48:2) 0.9244 0.7181 5.6086
TG (49:1) 1.3166 0.6704 2.3386
TG (49:2) 1.5841 0.5841 0.8426
TG (50:0) 1.6368 0.4479 2.1768
TG (50:1) 1.2446 0.6107 3.8747
TG (50:2) 1.4359 0.6319 1.6722
TG (50:3) 0.6219 1.1419 2.8411
TG (50:4) 0.9739 0.9652 1.7370
TG (51:1) 1.4764 0.5530 2.3450
TG (51:2) 1.4615 0.6026 1.8158
TG (51:3) 1.1532 0.8671 1.2839
TG (51:4) 1.4757 0.7001 0.3413
TG (52:0) 1.5390 0.5810 1.3362
TG (52:1) 1.5205 0.4291 3.5976
TG (52:2) 1.0351 0.8501 2.6977
TG (52:3) 0.9816 0.9729 1.5545
TG (52:4) 1.1694 0.8975 0.7071
TG (52:5) 1.3271 0.7940 0.5449
TG (52:6) 1.2342 0.8627 0.5347
TG (53:3) 1.4213 0.6863 1.0742
TG (53:4) 1.6537 0.5603 0.4721
TG (53:5) 1.1670 0.9246 0.3608
TG (54:1) 1.4763 0.5712 2.0973
TG (54:2) 1.5129 0.5161 2.4847
TG (54:3) 1.4074 0.6874 1.1990
TG (54:4) 1.4491 0.6854 0.8089
TG (54:5) 1.4703 0.6926 0.4971
TG (54:6) 1.7680 0.5001 0.1530
TG 54:7;TG(16:0/18:2/20:5) 1.9352 0.3826 0.0863
TG (54:8) 1.4082 0.7584 0.2205
TG 55:4 1.5583 0.6477 0.2311
TG (56:1) 1.2087 0.8027 1.6099
TG (56:2) 1.2824 0.8029 0.8703
TG (56:3) 1.2018 0.8818 0.5967
TG (56:4) 0.9296 1.1011 0.3226
TG (56:5) 1.2288 0.8629 0.5856
TG (56:6) 0.9616 1.0608 0.5527
TG (56:7) 1.0525 1.0161 0.2540
TG (56:8) 1.4032 0.7743 0.0519
TG (58:10) 1.5447 0.6728 0.0250
TG (58:2) 1.2997 0.7583 1.3063
TG (58:3) 1.3973 0.7113 0.9736
TG (58:4) A 1.1513 0.9407 0.2967
TG 58:5 1.1527 0.9312 0.4124
TG (58:6) 1.0650 1.0002 0.3482
TG (58:8) 1.6358 0.6032 0.0645
TG (58:9) 1.4676 0.7276 0.0466
Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

Factors:

F1Diagnosis:diabetic
F2Diagnosis:non-diabetic
F3Diagnosis:QC - quality check sample
  logo